MedTrace Logo

Investigating the Dose Response of an Almond-enriched Diet on Optimizing HDL-C in a Population With Hypercholesterolemia

NCT05174663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-01-30

No results posted yet for this study

Summary

This study will determine the quantity of almonds (1.5 oz or 2.5 oz) consumed as a snack that will provide optimal increases in HDL-C levels.

Conditions

Interventions

OTHER

Almond-enriched diet - 1.5 oz

Participants will receive 1.5 oz of almonds consumed as a snack daily for 16 weeks.

OTHER

Almond-enriched diet - 2.5 oz

Participants will receive 2.5 oz of almonds consumed as a snack daily for 16 weeks.

OTHER

Control snack

Participants will receive a control snack daily for 16 weeks.

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Almond Board of California

    lead OTHER

Principal Investigators

  • David Crowley, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2023-11-18
Completion
2023-11-18

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05174663 on ClinicalTrials.gov